These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27918244)

  • 41. Effects of UGT2B7, SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures.
    Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2018 May; 58():96-100. PubMed ID: 29679912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infantile Epileptic Encephalopathy Associated With SCN2A Mutation Responsive to Oral Mexiletine.
    Foster LA; Johnson MR; MacDonald JT; Karachunski PI; Henry TR; Nascene DR; Moran BP; Raymond GV
    Pediatr Neurol; 2017 Jan; 66():108-111. PubMed ID: 27867041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients.
    Sun YX; Zhuo WY; Lin H; Peng ZK; Wang HM; Huang HW; Luo YH; Tang FQ
    Epilepsy Res; 2015 Aug; 114():78-80. PubMed ID: 26088889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone mineral metabolism changes in epileptic children receiving valproic acid.
    Oner N; Kaya M; Karasalihoğlu S; Karaca H; Celtik C; Tütüncüler F
    J Paediatr Child Health; 2004 Aug; 40(8):470-3. PubMed ID: 15265190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
    Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
    Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of CPS14217C>A genotype on valproic-acid-induced hyperammonemia.
    Yagi M; Nakamura T; Okizuka Y; Oyazato Y; Kawasaki Y; Tsuneishi S; Sakaeda T; Matsuo M; Okumura K; Okamura N
    Pediatr Int; 2010 Oct; 52(5):744-8. PubMed ID: 20456087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.
    Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A
    Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy.
    Chen ZJ; Wang XD; Wang HS; Chen SD; Zhou LM; Li JL; Shu WY; Zhou JQ; Fang ZY; Zhang Y; Huang M
    Seizure; 2012 Mar; 21(2):110-7. PubMed ID: 22055352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of UGT2B7 genetic variants on serum valproic acid concentration.
    Ma H; Zhang T; Gong Z; Zhou B; Zou M; Xiao S; Zhu W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):766-72. PubMed ID: 23981985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroinformatics analyses reveal GABAt and SSADH as major proteins involved in anticonvulsant activity of valproic acid.
    Piplani S; Verma PK; Kumar A
    Biomed Pharmacother; 2016 Jul; 81():402-410. PubMed ID: 27261619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate.
    Hirfanoglu T; Serdaroglu A; Camurdan O; Cansu A; Bideci A; Cinaz P; Gucuyener K
    Pediatr Int; 2007 Dec; 49(6):822-6. PubMed ID: 18045279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary metabolites of valproic acid in epileptic patients.
    Katayama H; Watanabe M; Yoshitomi H; Yoshida H; Kimoto H; Kamiya A; Hayashi T; Akimura T
    Biol Pharm Bull; 1998 Mar; 21(3):304-7. PubMed ID: 9556166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of MDR1 and UGT Gene Polymorphisms on Sodium Valproate Plasma Concentration in Patients with Epilepsy.
    Song C; Li X; Zhang H; Bao J; Lu W; Peng Q; Zhang Y
    Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Valproic acid concentration and biochemical indexes in epilepsy outpatients during monotherapy or combination therapy.
    Yang X; Wang P; Pan J; Wang C; Luo J; Ma H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):782-789. PubMed ID: 32879081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Free valproic acid: steady-state pharmacokinetics in patients with intractable epilepsy.
    Otten N; Hall K; Irvine-Meek J; Leroux M; Budnik D; Seshia S
    Can J Neurol Sci; 1984 Nov; 11(4):457-60. PubMed ID: 6440705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of valproate sodium on pituitary gonadotropin in adolescent girls with epilepsy].
    Cai YH; Wang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Sep; 13(9):725-7. PubMed ID: 21924021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS.
    Werner T; Treiss I; Kohlmueller D; Mehlem P; Teich M; Longin E; Gerstner T; Koenig SA; Schulze A
    Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy.
    Dwivedi R; Gupta YK; Singh M; Joshi R; Tiwari P; Kaleekal T; Tripathi M
    Seizure; 2015 Feb; 25():187-90. PubMed ID: 25455060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.